Anne Schōnbrunn

Title: Anne Schōnbrunn: Innovator in Regulatory T Cell Research

Introduction

Anne Schōnbrunn is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of immunology, particularly in the identification and separation of regulatory T cells. Her innovative work has led to the development of a patented method that enhances the understanding of immune responses.

Latest Patents

Anne Schōnbrunn holds a patent for the invention titled "Use of the 4-1BB receptor for identifying and/or separating activated regulatory Th cells (Treg)." This invention relates to the use of the 4-1BB receptor for identifying and separating specific regulatory Th cells after activation with an antigen. It also includes a method for the identification and separation of regulatory Th cells, which are detected based on the expression of the 4-1BB receptor. The invention encompasses a kit that includes an antibody, antigen, or ligands for detecting the 4-1BB receptor, facilitating the identification and separation of regulatory Th cells.

Career Highlights

Anne Schōnbrunn is currently associated with Miltenyi Biotec GmbH, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of T cell regulation and its implications for therapeutic applications.

Collaborations

Anne has collaborated with notable colleagues, including Marco Frentsch and Andreas Thiel, to further her research initiatives. These collaborations have enriched her work and contributed to the advancement of immunological studies.

Conclusion

Anne Schōnbrunn is a trailblazer in the field of immunology, with her innovative patent and collaborative efforts paving the way for future advancements in regulatory T cell research. Her contributions are vital for the ongoing exploration of immune system dynamics.